A Randomized Controlled Trial to Compare High-Flow Nasal Cannula with Nasal CPAP after Extubation in Preterm infants

A Randomized Controlled Trial to Compare High-Flow Nasal Cannula with Nasal CPAP after Extubation in Preterm infants - HFNC Versus NCPAP for Extubated Preterm Infants

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013906

Enrollment

160

Registered

2014-07-01

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal respiratory disorders

Interventions

High-Flow Nasal Cannula group Nasal CPAP group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Preterm infants between 22 and 33 weeks of gestational age

Exclusion criteria

Exclusion criteria: Chromosomal anomalies, Major congenital anomalies

Design outcomes

Primary

Measure	Time frame
The incidence of re-intubation within 7 days after extubation	—

Secondary

Measure	Time frame
The incidence of complications, tolerability	—

Countries

Japan

Contacts

Public ContactAtsushi Uchiyama

Tokai University School of Medicine Department of Pediatrics,

uchiyama.atsushi@tsc.u-tokai.ac.jp0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026